Question
Consider the following common size statements: 1 2 3 4 5 Balance sheet Cash and marketable securities 5% 6% 7% 11% 72% Receivables 11% 3%
Consider the following common size statements:
1 | 2 | 3 | 4 | 5 | |
Balance sheet | |||||
Cash and marketable securities | 5% | 6% | 7% | 11% | 72% |
Receivables | 11% | 3% | 8% | 12% | 2% |
Inventories | 9% | 4% | 6% | 13% | 2% |
Other non-current assets | 2% | 3% | 3% | 5% | 4% |
PPE and fixed assets | 21% | 71% | 14% | 26% | 2% |
Goodwill | 31% | 0% | 25% | 19% | 0% |
Other intangibles | 15% | 5% | 22% | 2% | 17% |
Investments and other financial assets | 1% | 2% | 9% | 2% | 0% |
Other assets | 6% | 6% | 7% | 10% | 0% |
Total assets | 100% | 100% | 100% | 100% | 100% |
Current liabilities | 38% | 11% | 21% | 49% | 37% |
Long-term debt | 16% | 33% | 9% | 17% | 0% |
Other non-current liabilities | 13% | 10% | 11% | 14% | 5% |
Shareholders' equity | 33% | 46% | 59% | 20% | 58% |
Total L+ SE | 100% | 100% | 100% | 100% | 100% |
Income statement | |||||
Net Revenues | 100% | 100% | 100% | 100% | 100% |
COGS (including depreciation) | -57% | -77% | -33% | -78% | -31% |
SGA | -26% | -11% | -30% | -19% | -292% |
Interest expense | -1% | -2% | -1% | -1% | -2% |
R&D | -2% | -1% | -17% | 0% | -276% |
Income tax expense/benefit | -4% | -2% | -2% | -1% | -8% |
Other items | -1% | 0% | -1% | 0% | 42% |
Net income | 10% | 8% | 16% | 2% | -467% |
Match Company 1 with its business sector.
A)Bio-tech
B)Consumer goods
C)Oil
D)Pharmaceutical
E)Retail
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started